Outcome of Corynebacterial Bloodstream Infection in Patients With Cardiac Implantable Electronic Devices: A Brief Report and Systematic Review

Supavit Chesdachai; Larry M Baddour; M Rizwan Sohail; Bharath Raj Palraj; Malini Madhavan; Hussam Tabaja; Michele T McGinnis; Madiha Fida; Douglas W Challener; Daniel C DeSimone

doi:10.1093/ofid/ofae441

Outcome of Corynebacterial Bloodstream Infection in Patients With Cardiac Implantable Electronic Devices: A Brief Report and Systematic Review

Open Forum Infect Dis. 2024 Jul 29;11(8):ofae441. doi: 10.1093/ofid/ofae441. eCollection 2024 Aug.

Authors

Affiliations

¹ Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
³ Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
⁴ Mayo Clinic Libraries, Mayo Clinic, Rochester, Minnesota, USA.

Abstract

Cardiac implantable electronic device infection in the context of corynebacterial bloodstream infection (BSI) remains poorly understood. From 2012 to 2023 at Mayo Clinic, 4 of 12 patients with corynebacterial BSI had cardiac implantable electronic device infection: 1 patient was diagnosed during a relapsing BSI episode. Undefined source, persistent BSI, and the presence of a prosthetic cardiac valve were common characteristics.

Keywords: Corynebacterium; bloodstream infection; cardiac implantable electronic device; infection; relapse.